Delivery Order SPE2DR25D1202-SPE2DR26F71ML
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,549.99 to AmerisourceBergen Drug Corp on September 8, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition without a set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a $11,008.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $5,179.06 for OmniPod 5 Dexcom G7 generation 5 insulin delivery pods. This is a firm fixed price, non-set-aside contract with a completion date of September 25, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $24,265.08 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract represents a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods valued at $1,222.32. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,184.11 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This non-competitive delivery order, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed price transaction under DLA's pharmaceutical supply chain. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,193.52 to AmerisourceBergen Drug Corp on June 3, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitive award, with no set-aside designation, was issued under firm fixed pricing and is scheduled for completion by June 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is supported by...
- The Defense Logistics Agency awarded a $2,499.84 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, which became effective on September 10, 2025, with completion targeted for September 11, 2025, utilizes firm fixed pricing with no set-aside designation and was competitively awarded. Performance will be executed from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. This delivery order represents a child...